You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 561 DuoBody®-PD-L1×4–1BB (GEN1046) induces superior immune-cell activation, cytokine production and cytotoxicity by combining PD-L1 blockade with conditional 4–1BB co-stimulation

Citation Tools

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Immune-stimulants and immune modulators
561 DuoBody®-PD-L1×4–1BB (GEN1046) induces superior immune-cell activation, cytokine production and cytotoxicity by combining PD-L1 blockade with conditional 4–1BB co-stimulation

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Muik A, Altintas I, Kosoff R, et al
561 DuoBody®-PD-L1×4–1BB (GEN1046) induces superior immune-cell activation, cytokine production and cytotoxicity by combining PD-L1 blockade with conditional 4–1BB co-stimulation
Journal for ImmunoTherapy of Cancer 2020;8:doi: 10.1136/jitc-2020-SITC2020.0561